Sara Torrecilla

Publicaciones destacadas

• Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial

  Autores:

  Pinyol R; Montal R; Bassaganyas L; Sia D; Takayama T;

  (...)

  Villanueva A; Pena C; Meinhardt G; Bruix J; Llovet JM.

  Ver listado completo de autores

  Referencia: GUT 2019.

• MOLECULAR CHARACTERIZATION OF HBV/HDV-RELATED HCC IN MONGOLIA

  Autores:

  Puigvehi, Marc; Torres-Martin, Miguel; Maeda, Miho; Orlando, Vincenzo; Wang, Huan;

  (...)

  Chinburen, Jigjidsuren; Forns, Xavier; Roayaie, Sasan; Sia, Daniela; Llovet, Josep M.;.

  Ver listado completo de autores

  Referencia: HEPATOLOGY 2019.

• Trunk events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma.

  Autores:

  Torrecilla, Sara; Sia, Daniela; Harrington, Andrew N; Zhang, Zhongyang; Cabellos, Laia;

  (...)

  Thung, Swan N; Villanueva, Augusto; Florman, Sander; Schwartz, Myron E; Llovet, Josep M.

  Ver listado completo de autores

  Referencia: Journal Of Hepatology 2017.

• Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma

  Autores:

  Tovar, Victoria; Cornella, Helena; Moeini, Agrin; Vidal, Samuel; Hoshida, Yujin;

  (...)

  Desbois-Mouthon, Christele; Sole, Manel; Domingo-Domenech, Josep; Villanueva, Augusto; Llovet, Josep M.;.

  Ver listado completo de autores

  Referencia: GUT 2017.

• IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models

  Autores:

  Martinez-Quetglas I.; Pinyol R.; Dauch D.; Torrecilla S.; Tovar V.;

  (...)

  Villanueva A.; Thung S.; Esteller M.; Zender L.; Llovet J..

  Ver listado completo de autores

  Referencia: GASTROENTEROLOGY 2016.

• New molecular therapies for hepatocellular carcinoma

  Autores:

  Torrecilla S; Llovet JM ;

  Referencia: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY 2015.